BioCryst Pharmaceuticals
BCRX
7.22
-0.10
-1.37%
BioCryst Pharmaceuticals
US · BCRX
#2766 by market cap
Listed 1970
7.22
-0.10
-1.37%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
- Founded
- 1986
- CEO
- Mr. Charles K. Gayer
- Employees
- 435
- Headquarters
- Durham, North Carolina, United States of America
- Fiscal year end
- 12-31
- Website
- biocryst.com
Company profile
- Exchange
- US
- Symbol
- BCRX
- Market-cap rank
- #2766
- Listing date
- 1970-01-01
- Market cap
- 1.86B
- Float cap
- 1.73B
- Shares out
- 257.30M
- Float shares
- 239.51M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-11-20 20:02:40 · For reference only, not investment advice and not tailored to your situation.
BioCryst Pharmaceuticals discussion 0 comments